244 related articles for article (PubMed ID: 29356704)
1. Familial hypercholesterolemia: experience from the French-Canadian population.
Paquette M; Genest J; Baass A
Curr Opin Lipidol; 2018 Apr; 29(2):59-64. PubMed ID: 29356704
[TBL] [Abstract][Full Text] [Related]
2. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
Jensen HK
Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
[TBL] [Abstract][Full Text] [Related]
3. Familial hypercholesterolemia: molecular, biochemical, and clinical characterization of a French-Canadian pediatric population.
Assouline L; Levy E; Feoli-Fonseca JC; Godbout C; Lambert M
Pediatrics; 1995 Aug; 96(2 Pt 1):239-46. PubMed ID: 7630677
[TBL] [Abstract][Full Text] [Related]
4. Familial hypercholesterolemia: experience from France.
Rabès JP; Béliard S; Carrié A
Curr Opin Lipidol; 2018 Apr; 29(2):65-71. PubMed ID: 29389714
[TBL] [Abstract][Full Text] [Related]
5. [Familial hypercholesterolemia: A largely underestimated cardiovascular risk].
Ferrières J; Bruckert É; Béliard S; Rabès JP; Farnier M; Krempf M; Cariou B; Danchin N
Ann Cardiol Angeiol (Paris); 2018 Feb; 67(1):1-8. PubMed ID: 28576280
[TBL] [Abstract][Full Text] [Related]
6. Familial hypercholesterolemia: is it time to separate monogenic from polygenic familial hypercholesterolemia?
Brandts J; Dharmayat KI; Ray KK; Vallejo-Vaz AJ
Curr Opin Lipidol; 2020 Jun; 31(3):111-118. PubMed ID: 32332432
[TBL] [Abstract][Full Text] [Related]
7. Predicting cardiovascular disease in familial hypercholesterolemia.
Paquette M; Baass A
Curr Opin Lipidol; 2018 Aug; 29(4):299-306. PubMed ID: 29708923
[TBL] [Abstract][Full Text] [Related]
8. Homozygous Familial Hypercholesterolemia in Spain: Prevalence and Phenotype-Genotype Relationship.
Sánchez-Hernández RM; Civeira F; Stef M; Perez-Calahorra S; Almagro F; Plana N; Novoa FJ; Sáenz-Aranzubía P; Mosquera D; Soler C; Fuentes FJ; Brito-Casillas Y; Real JT; Blanco-Vaca F; Ascaso JF; Pocovi M
Circ Cardiovasc Genet; 2016 Dec; 9(6):504-510. PubMed ID: 27784735
[TBL] [Abstract][Full Text] [Related]
9. Population specific genetic heterogeneity of familial hypercholesterolemia in South Africa.
Smyth N; Ramsay M; Raal FJ
Curr Opin Lipidol; 2018 Apr; 29(2):72-79. PubMed ID: 29369830
[TBL] [Abstract][Full Text] [Related]
10. Severe heterozygous familial hypercholesterolemia and risk for cardiovascular disease: a study of a cohort of 14,000 mutation carriers.
Besseling J; Kindt I; Hof M; Kastelein JJ; Hutten BA; Hovingh GK
Atherosclerosis; 2014 Mar; 233(1):219-23. PubMed ID: 24529147
[TBL] [Abstract][Full Text] [Related]
11. A systematic review of current studies in patients with familial hypercholesterolemia by use of national familial hypercholesterolemia registries.
Mundal L; Retterstøl K
Curr Opin Lipidol; 2016 Aug; 27(4):388-97. PubMed ID: 27070076
[TBL] [Abstract][Full Text] [Related]
12. Phenotype vs. genotype in severe familial hypercholesterolemia: what matters most for the clinician?
Santos RD
Curr Opin Lipidol; 2017 Apr; 28(2):130-135. PubMed ID: 28059950
[TBL] [Abstract][Full Text] [Related]
13. Atherosclerotic cardiovascular disease risk assessment in familial hypercholesterolemia: does one size fit all?
Mata P; Alonso R; Pérez de Isla L
Curr Opin Lipidol; 2018 Dec; 29(6):445-452. PubMed ID: 30382952
[TBL] [Abstract][Full Text] [Related]
14. Identifying familial hypercholesterolemia in acute coronary syndrome.
Gencer B; Nanchen D
Curr Opin Lipidol; 2016 Aug; 27(4):375-81. PubMed ID: 27092769
[TBL] [Abstract][Full Text] [Related]
15. The role of registries and genetic databases in familial hypercholesterolemia.
Kindt I; Mata P; Knowles JW
Curr Opin Lipidol; 2017 Apr; 28(2):152-160. PubMed ID: 28169870
[TBL] [Abstract][Full Text] [Related]
16. Low density lipoprotein receptor (LDLR) gene mutations in Canadian subjects with familial hypercholesterolemia, but not of French descent.
Wang J; Huff E; Janecka L; Hegele RA
Hum Mutat; 2001 Oct; 18(4):359. PubMed ID: 11668627
[TBL] [Abstract][Full Text] [Related]
17. Homozygous familial hypercholesterolemia among French Canadians in Québec Province.
Moorjani S; Roy M; Gagné C; Davignon J; Brun D; Toussaint M; Lambert M; Campeau L; Blaichman S; Lupien P
Arteriosclerosis; 1989; 9(2):211-6. PubMed ID: 2923577
[TBL] [Abstract][Full Text] [Related]
18. Causative mutations and premature cardiovascular disease in patients with heterozygous familial hypercholesterolaemia.
Rubba P; Gentile M; Marotta G; Iannuzzi A; Sodano M; De Simone B; Jossa F; Iannuzzo G; Giacobbe C; Di Taranto MD; Fortunato G
Eur J Prev Cardiol; 2017 Jul; 24(10):1051-1059. PubMed ID: 28353356
[TBL] [Abstract][Full Text] [Related]
19. Simplified Canadian Definition for Familial Hypercholesterolemia.
Ruel I; Brisson D; Aljenedil S; Awan Z; Baass A; Bélanger A; Bergeron J; Bewick D; Brophy JM; Brunham LR; Couture P; Dufour R; Francis GA; Frohlich J; Gagné C; Gaudet D; Grégoire JC; Gupta M; Hegele RA; Mancini GBJ; McCrindle BW; Pang J; Raggi P; Tu JV; Watts GF; Genest J
Can J Cardiol; 2018 Sep; 34(9):1210-1214. PubMed ID: 30093300
[TBL] [Abstract][Full Text] [Related]
20. Common low-density lipoprotein receptor mutations in the French Canadian population.
Leitersdorf E; Tobin EJ; Davignon J; Hobbs HH
J Clin Invest; 1990 Apr; 85(4):1014-23. PubMed ID: 2318961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
